Package 31722-759-30

{"route": ["ORAL"], "spl_id": "04d99965-cea0-8e7d-e063-6394a90ab281", "openfda": {"nui": ["N0000008832", "N0000182142", "N0000182143", "N0000187062"], "upc": ["0331722759304", "0331722758307"], "unii": ["A74586SNO7"], "rxcui": ["309362", "749196"], "spl_set_id": ["b573aefa-e337-478f-97e4-eb8472a7e497"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (31722-759-05)", "package_ndc": "31722-759-05", "marketing_start_date": "20230804"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (31722-759-30)", "package_ndc": "31722-759-30", "marketing_start_date": "20230804"}], "brand_name": "CLOPIDOGREL", "product_id": "31722-759_04d99965-cea0-8e7d-e063-6394a90ab281", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "31722-759", "generic_name": "CLOPIDOGREL", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CLOPIDOGREL", "active_ingredients": [{"name": "CLOPIDOGREL", "strength": "300 mg/1"}], "application_number": "ANDA205345", "marketing_category": "ANDA", "marketing_start_date": "20230804", "listing_expiration_date": "20261231"}